NOAEL Studies
Cosmetic Ingredient
3-Nitro-P-Hydroxyethylaminophenol NOAEL Studies
CAS: 65235-31-6
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 100 | mg/kg bw/day | rat | oral | 6-15 Gestation day | Developmental | SCCP; M.H. Savary. IMEXINE FH: Assessment of possible embryotoxic orteratogenic effects by oral route in rats. CIT, Study N°5842 RSR |
NTP ICE skin sensitization 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP ICE skin sensitization | EC3 | 0.1 | % | Mouse | Dermal | - | In Vivo; LLNAdb2013; LLNA | sheet=Data_invivo; excel_row=13339; Record_ID=skin_sensitization_invivo_3454; Data_Type=In Vivo; Internal_Data_Source=LLNAdb2013; Mixture=Chemical; DTXSID=DTXSID00215536; Assay=LLNA; Endpoint=EC3; Response=0.1; Response_Unit=%; Species=Mouse; Route=Dermal; Reference=Kern et al. 2010; 20137736; Not available; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID00215536 |
SCCS Opinion 6 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =15 | % | - | - | Chronic | NOAEL study | p.13 |
| SCCS Opinion | NOAEL | =100 | mg/kg/day | rat | - | developmental | developmental toxicity | Ref: 11a and 11b 3, p.21 |
| SCCS Opinion | NOAEL | =100 | mg/kg | rat | oral | developmental | developmental toxicity | p.22 |
| SCCS Opinion | NOAEL | =200 | mg/kg bw/day | rat | - | 90-day | NOAEL study | p.22 |
| SCCS Opinion | NOAEL | =1000 | mg/kg/day | rat | oral | - | NOAEL study | p.13 |
| SCCS Opinion | NOAEL | =1000 | mg/kg | rat | - | developmental | developmental toxicity | p.21 |
Regulatory source 8 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 15 | % | - | - | Chronic | - | p.13 |
| Regulatory source | - | 200 | mg/kg bw/day | rat | - | 90-day | - | p.22 |
| Regulatory source | - | 1000 | mg/kg/day | rat | oral | - | - | p.13 |
| Regulatory source | developmental toxicity | 100 | mg/kg/day | rat | - | developmental | developmental toxicity | p.21 |
| Regulatory source | developmental toxicity | 100 | mg/kg/day | human | - | developmental | developmental toxicity | p.21 |
| Regulatory source | developmental toxicity | =100 | mg/kg | rat | oral | developmental | developmental toxicity | p.22 |
| Regulatory source | developmental toxicity | 100 | mg/kg/day | rabbit | dermal | developmental | developmental toxicity | p.23 |
| Regulatory source | developmental toxicity | 1000 | mg/kg | rat | - | developmental | developmental toxicity | p.21 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | AIP2J155AN | UNII | - | - | - | chemical | - |